Literature DB >> 21703524

Incidence, correlates, and consequences of acute kidney injury in patients with pulmonary arterial hypertension hospitalized with acute right-side heart failure.

François Haddad1, Eric Fuh, Tyler Peterson, Mehdi Skhiri, Kristina T Kudelko, Vinicio De Jesus Perez, Wolfgang C Winkelmayer, Ramona L Doyle, Glenn M Chertow, Roham T Zamanian.   

Abstract

BACKGROUND: Though much is known about the prognostic influence of acute kidney injury (AKI) in left-side heart failure, much less is known about AKI in patients with pulmonary arterial hypertension (PAH). METHODS AND
RESULTS: We identified consecutive patients with PAH who were hospitalized at Stanford Hospital for acute right-side heart failure. AKI was diagnosed according to the criteria of the Acute Kidney Injury Network. From June 1999 to June 2009, 105 patients with PAH were hospitalized for acute right-side heart failure (184 hospitalizations). AKI occurred in 43 hospitalizations (23%) in 34 patients (32%). The odds of developing AKI were higher among patients with chronic kidney disease (odds ratio [OR] 3.9, 95% confidence interval [CI] 1.8-8.5), high central venous pressure (OR 1.8, 95% CI 1.1-2.4, per 5 mm Hg), and tachycardia on admission (OR 4.3, 95% CI 2.1-8.8). AKI was strongly associated with 30-day mortality after acute right-side heart failure hospitalization (OR 5.3, 95% CI 2.2-13.2).
CONCLUSIONS: AKI is relatively common in patients with PAH and associated with a short-term risk of death.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21703524     DOI: 10.1016/j.cardfail.2011.03.003

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  17 in total

1.  Trends in pediatric pulmonary hypertension-related hospitalizations in the United States from 2000-2009.

Authors:  David B Frank; Matthew A Crystal; David L S Morales; Ken Gerald; Brian D Hanna; George B Mallory; Joseph W Rossano
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

2.  Right Heart Failure-Unrecognized Cause of Cardiorenal Syndrome.

Authors:  Shweta Bansal; Anand Prasad; Stuart Linas
Journal:  J Am Soc Nephrol       Date:  2018-05-15       Impact factor: 10.121

Review 3.  Cardiorenal [corrected] syndrome: an emerging problem in pediatric critical care.

Authors:  John Lynn Jefferies; Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2012-07-18       Impact factor: 3.714

Review 4.  Cardiac Ultrasound for the Nephrologist: Know Thy Heart to Know Thy Kidneys.

Authors:  Pankaj Goyal; Joseph Minardi; Ankit Sakhuja
Journal:  Adv Chronic Kidney Dis       Date:  2021-05       Impact factor: 3.620

Review 5.  Right Heart Function in Cardiorenal Syndrome.

Authors:  Tilmann Kramer; Paul Brinkkoetter; Stephan Rosenkranz
Journal:  Curr Heart Fail Rep       Date:  2022-09-27

6.  Presence and outcomes of kidney disease in patients with pulmonary hypertension.

Authors:  Sankar D Navaneethan; Edgard Wehbe; Gustavo A Heresi; Varun Gaur; Omar A Minai; Susana Arrigain; Joseph V Nally; Jesse D Schold; Mahboob Rahman; Raed A Dweik
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 8.237

7.  Assessing the effect of preoperative levosimendan on renal function in patients with right ventricular dysfunction.

Authors:  Jose L Guerrero Orriach; M Galán Ortega; A Ramírez Fernandez; D Ariza Villanueva; A Florez Vela; I Moreno Cortés; M Rubio Navarro; J Cruz Mañas
Journal:  J Clin Monit Comput       Date:  2016-01-13       Impact factor: 2.502

8.  Renal replacement therapy as a therapeutic option for right heart failure in severe pulmonary arterial hypertension.

Authors:  Mai Shimbo; Masaru Hatano; Satoshi Ishii; Akihito Saito; Hiroki Yagi; Shun Minatsuki; Hisataka Maki; Eisuke Amiya; Norifumi Takeda; Issei Komuro
Journal:  ESC Heart Fail       Date:  2022-04-16

9.  N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pre-capillary pulmonary hypertension and renal insufficiency.

Authors:  Lars Harbaum; Jan K Hennigs; Hans J Baumann; Nicole Lüneburg; Elisabeth Griesch; Carsten Bokemeyer; Ekkehard Grünig; Hans Klose
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

Review 10.  Macrophage Migration Inhibitory Factor in Clinical Kidney Disease.

Authors:  Annette Bruchfeld; Mårten Wendt; Edmund J Miller
Journal:  Front Immunol       Date:  2016-01-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.